Jump to content

Talk:Serotonin–norepinephrine reuptake inhibitor

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia


Wiki Education assignment: Psychology Capstone

[edit]

This article was the subject of a Wiki Education Foundation-supported course assignment, between 26 August 2024 and 6 December 2024. Further details are available on the course page. Student editor(s): SFronduti (article contribs). Peer reviewers: Makylam18, Carolinedean31, Sarah3102, Anlntph, Matthewpalmer03.

— Assignment last updated by Aronov13 (talk) 03:30, 6 October 2024 (UTC)[reply]

Adding information to 'special populations' section providing more in-depth detail for each category and further citations. SFronduti (talk) 02:20, 20 October 2024 (UTC)[reply]

Removed "migraine prevention" from Intro. Latest research from 2018 shows that data does not show sufficient effectiveness in prevention. See C. Sialakis, P. Antoniou. The effect of the selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors in prevention of the tension type headache and migraine: overview of Cochrane and non-Cochrane reviews. Scientific Chronicles 2018; 23(3): 288-302 eoi: http://eoi.citefactor.org/10.11212/exronika/2018.3.4 SFronduti (talk) 05:10, 10 November 2024 (UTC)[reply]